期刊
MAYO CLINIC PROCEEDINGS
卷 86, 期 9, 页码 885-893出版社
ELSEVIER SCIENCE INC
DOI: 10.4065/mcp.2011.0332
关键词
-
资金
- Elan/Wyeth Alzheimer's Immunotherapy Program North American Advisory Board
- Novartis
- Alzheimer's Association, Forest, University of California
- University Medical School
- Colloquium Paris
- Ipsen
- Wenner-Gren Foundations
- Social Security Administration
- Korean Neurological Association
- National Institutes of Health
- Washington University at St. Louis
- Banner Alzheimer's Institute
- Veterans Affairs Central Office, Beijing Institute of Geriatrics, Innogenetics
- New York University
- Neuro Vigil, Inc
- CHRU-Hopital Roger Salengro
- Siemens
- AstraZeneca
- Geneva University Hospitals
- Lilly
- University of California
- San Diego-ADNI
- Paris University
- Institut Catala de Neurosciencies Aplicades
- University of New Mexico School of Medicine
- Pfizer
- NIA
Elderly patients who have an acute Illness or who undergo surgery often experience cognitive decline. The pathophysiologic mechanisms that cause neurodegeneration resulting in cognitive decline, including protein deposition and neuroInflammation, also play a role in animal models of surgery-Induced cognitive decline. With the aging of the population, surgical candidates of advanced age with underlying neurodegeneration are encountered more often, raising concerns that, in patients with this combination, cognitive function will precipitously decline postoperatively. This special article is based on a symposium that the University of California, San Francisco, convened to explore the contributions of surgery and anesthesia to the development of cognitive decline In the aged patient. A road map to further elucidate the mechanisms, diagnosis, risk factors, mitigation, and treatment of postoperative cognitive decline in the elderly is provided.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据